Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 7;11(4):e7138.
doi: 10.1002/ccr3.7138. eCollection 2023 Apr.

Temperature management using an intervascular cooling device for a COVID-19 patient with refractory hyperthermia

Yuya Yoshino  1 , Michihito Kyo  1 , Shinichiro Ohshimo  1 , Nobuaki Shime  1
Affiliations
Case Reports

Temperature management using an intervascular cooling device for a COVID-19 patient with refractory hyperthermia

Yuya Yoshino et al. Clin Case Rep. .

Abstract

COVID-19 is a life-threatening disease complicated by hyperinflammation followed by multi-organ failure. Although refractory hyperthermia in COVID-19 contributes to an unfavorable prognosis, little is known about effective interventions. We present a case of successful temperature management using an intravascular cooling device in a patient with COVID-19 who developed refractory hyperthermia.

Keywords: coronavirus; hyperpyrexia; temperature control.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Clinical course of the patient. The graph shows the clinical course of a patient with COVID‐19 who developed refractory hyperthermia. On day 15, cooling with an intravascular cooling device was initiated for refractory hyperthermia (41.2°C) to achieve the target body temperature of 38.0°C. Closed circle, body temperature; open circle, PaO2/FIO2 ratio; closed triangle, serum lactate level.
See this image and copyright information in PMC

References

    1. Czepiel KS, Lucas AT, Whalen MJ, Mojica JE. Dexmedetomidine‐associated hyperpyrexia in three critically ill patients with coronavirus disease 2019. Crit Care Explor. 2020;2(9):e0213. - PMC - PubMed
    1. Suwanwongse K, Shabarek N. Hyperpyrexia in patients with COVID‐19. J Med Virol. 2020;92(11):2857‐2862. - PMC - PubMed
    1. Choron RL, Butts CA, Bargoud C, et al. Fever in the ICU: a predictor of mortality in mechanically ventilated COVID‐19 patients. J Intensive Care Med. 2021;36(4):484‐493. - PMC - PubMed
    1. Schortgen F, Clabault K, Katsahian S, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012;185(10):1088‐1095. - PubMed
    1. Cruces P, Cores C, Casanova D, Pizarro F, Díaz F. Successful use of mild therapeutic hypothermia as compassionate treatment for severe refractory hypoxemia in COVID‐19. J Crit Care. 2021;63:260‐263. - PMC - PubMed

Publication types

LinkOut - more resources